Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 27-12-2024 |
Asset Class: |
Benchmark: BSE Healthcare TRI |
TER: 2.36% As on (28-02-2025) |
Status: Open Ended Schemes |
Minimum Investment: 0 |
Minimum Topup: 0 |
Total Assets: 283 Cr As on 28-02-2025(Source:AMFI) |
Turn over: - |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Standard Deviation | - |
Sharpe Ratio | - |
Alpha | - |
Beta | - |
Yield to Maturity | - |
Average Maturity | - |
Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
---|---|---|---|---|---|---|
BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH | 27-12-2024 | - | - | - | - | - |
HDFC Pharma and Healthcare Fund - Growth Option | 04-10-2023 | 29.56 | - | - | - | - |
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth | 06-02-2024 | 27.98 | - | - | - | - |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | 14-07-1999 | 20.79 | 38.64 | 22.99 | 30.42 | 11.65 |
UTI Healthcare Fund - Regular Plan - Growth Option | 05-08-2005 | 20.07 | 37.55 | 19.78 | 28.47 | 10.7 |
Small Cap
27.44%
Others
7.75%
Large Cap
38.79%
Mid Cap
26.02%